| Line Item | 2025-09-30 | Q/Q | Y/Y |
|---|---|---|---|
| Revenue | $2.7M | -21.3% | -50.5% |
| Cost of Revenue | $1.4M | +53.5% | -40.0% |
| Gross Profit | $1.3M | -47.8% | -58.1% |
| R&D Expense | $2.0M | +12.0% | -37.2% |
| SG&A Expense | $5.8M | +10.5% | -17.8% |
| Operating Income | -$9.6M | -38.5% | +22.0% |
| Pre-tax Income | -$11.9M |
| Line Item | 2025-09-30 | Q/Q | Y/Y |
|---|---|---|---|
| Cash & Equivalents | $6.1M | -51.8% | -78.6% |
| Accounts Receivable | $4.0M | -31.9% | -59.9% |
| Inventory | $3.7M | -2.8% | -19.8% |
| Current Assets | $14.6M | -37.9% | -67.4% |
| Total Assets | $18.1M | -35.6% | -64.2% |
| Current Liabilities |
| Line Item | 2025-09-30 | Q/Q | Y/Y |
|---|---|---|---|
| Operating Cash Flow | -$23.6M | — | — |
| Capital Expenditures | $611K | — | — |
| Investing Cash Flow | -$611K | — | — |
| Financing Cash Flow | $14.4M | — | — |
| Free Cash Flow | -$24.2M | — | — |
| -27.8% |
| -32.9% |
| Income Tax | $9K | -79.1% | -87.0% |
| Net Income | -$11.9M | -27.3% | -32.0% |
| EPS (Basic) | -$1.53 | -19.5% | -992.9% |
| EPS (Diluted) | -$1.53 | -19.5% | -992.9% |
| $11.6M |
| +0.0% |
| -39.6% |
| Total Liabilities | $101.1M | +9.7% | -11.7% |
| Stockholders' Equity | -$82.9M | -29.6% | -28.0% |